β¨ Medicines Distribution Consent
29 MARCH NEW ZEALAND GAZETTE 773
Product:
Active Ingredient(s):
Dosage Form:
New Zealand Sponsor:
Manufacturer(s):
Gengraf
Cyclosporin 100mg/mL
Oral solution
Abbott Laboratories (NZ) Limited
Abbott Laboratories Inc., Specialty Products Division, North Chicago, Illinois, United States of America
Product:
Active Ingredient(s):
Dosage Form:
New Zealand Sponsor:
Manufacturer(s):
Vioxx
Rofecoxib 50mg
Tablet
Merck Sharp & Dohme (New Zealand) Limited
Merck Manufacturing Division of Merck and Co, Bo. Sabana Hoyos, Arecibo, Puerto Rico
Merck Sharp and Dohme Australia Pty Limited, South Granville, New South Wales, Australia
Dated this 21st day of March 2001.
G. R. BOYD, Chief Advisor, Safety and Regulation (pursuant to delegation given by the Minister of Health on the 20th day of February 1997).
go2135
Consent to the Distribution of Changed Medicines
Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the changed medicines which were referred to the Minister of Health under the provisions of section 24 (5) of the Act and are set out in the Schedule hereto:
Schedule
Product:
Active Ingredient(s):
Dosage Form:
New Zealand Sponsor:
Manufacturer(s):
Metamucil Orange Flavour Smooth Texture
Ispaghula husk 578.85mg/g
Powder for oral solution
Procter & Gamble NPD Incorporated
Procter & Gamble Pharmaceuticals, Phoenix, Arizona, United States of America
Product:
Active Ingredient(s):
Dosage Form:
New Zealand Sponsor:
Manufacturer(s):
Metamucil Orange Flavour Smooth Texture
Ispaghula husk 534.7mg/g
Powder for oral solution
Procter & Gamble NPD Incorporated
Procter & Gamble Pharmaceuticals, Phoenix, Arizona, United States of America
Product:
Active Ingredient(s):
Dosage Form:
New Zealand Sponsor:
Manufacturer(s):
Metamucil Regular Flavour Original Texture
Ispaghula husk 49.14%w/w
Powder for oral solution
Procter & Gamble NPD Incorporated
Procter & Gamble Pharmaceuticals, Phoenix, Arizona, United States of America
Searle Division of Monsanto Australia Limited, Fairfield, New South Wales, Australia
Product:
Active Ingredient(s):
Dosage Form:
New Zealand Sponsor:
Manufacturer(s):
Roferon-A
Interferon alpha-2a 6MIU/mL
Solution for injection
Roche Products (New Zealand) Limited
F Hoffmann-La Roche AG, Basel, Switzerland
Product:
Active Ingredient(s):
Dosage Form:
New Zealand Sponsor:
Manufacturer(s):
Roferon-A
Interferon alpha-2a 9MIU/mL
Solution for injection
Roche Products (New Zealand) Limited
F Hoffmann-La Roche AG, Basel, Switzerland
Product:
Active Ingredient(s):
Dosage Form:
New Zealand Sponsor:
Manufacturer(s):
Roferon-A
Interferon alpha-2a 12MIU/mL
Solution for injection
Roche Products (New Zealand) Limited
F Hoffmann-La Roche AG, Basel, Switzerland
Product:
Active Ingredient(s):
Dosage Form:
New Zealand Sponsor:
Manufacturer(s):
Roferon-A
Interferon alpha-2a 18MIU/mL
Solution for injection
Roche Products (New Zealand) Limited
F Hoffmann-La Roche AG, Basel, Switzerland
Next Page →
Online Sources for this page:
VUW Te Waharoa —
NZ Gazette 2001, No 35
Gazette.govt.nz —
NZ Gazette 2001, No 35
β¨ LLM interpretation of page content
π₯ Consent to Distribution of New Medicines
π₯ Health & Social Welfare21 March 2001
Medicines Act, New medicines, Distribution consent, Gengraf, Vioxx, Abbott Laboratories, Merck Sharp & Dohme
- G. R. Boyd, Chief Advisor, Safety and Regulation
π₯ Consent to the Distribution of Changed Medicines
π₯ Health & Social WelfareMedicines Act, Changed medicines, Distribution consent, Metamucil, Roferon-A, Procter & Gamble, Roche Products